TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases
TenNor Therapeutics has raised $14.7M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
TenNor Therapeutics's investors include Northern Light Venture Capital, SNÖ Ventures, Oriza Holdings, AMR Action Fund, Oriza Ventures.
TenNor Therapeutics is headquartered in Westfield, United States.
TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases
TenNor Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TenNor Therapeutics — Funding & Investors." VCBacked, May 24, 2026, https://www.vcbacked.co/company/tennor-therapeutics. Accessed November 12, 2026.
VCBacked. (2026). TenNor Therapeutics — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/tennor-therapeutics
{{cite web |title=TenNor Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tennor-therapeutics |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at TenNor Therapeutics? Request a listing update